Current role
David Dornan
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David Dornan
The proxy statement of Bolt Biotherapeutics, Inc. reports total compensation of $2,231,676 for David Dornan in fiscal 2021, including a base salary of $405,000. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Whitehawk Therapeutics, Inc. (WHWK)
Proxy statement
CurrentStart not stated–present
-
Bolt Biotherapeutics, Inc. (BOLT)
Proxy statement
Start not stated–2022-04-28
Last confirmed by a filing; no departure on record
-
Bolt Biotherapeutics, Inc. (BOLT)
Proxy statement
Start not stated–2022-03-11
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Whitehawk Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Brendan Delaney CEO, COO, Board Member
- David J. Lennon CEO, Board Member
- David Lennon CEO, Board Member
- Neil Desai, Ph.D. CEO, Board Member
- Stephen Hoffman CEO
- Caley Castelein, M.D. Chairman
- Neil Desai Chairman, Board Member
- Lance Thibault CFO
- Scott Giacobello CFO, Chief Accounting Officer
- Anupam Dalal Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Bolt Biotherapeutics, Inc. (BOLT) | Former Chief Scientific Officer | $405,000 | $2,231,676 |
| 2020 | Bolt Biotherapeutics, Inc. (BOLT) | Former Chief Scientific Officer | $310,167 | $576,781 |
Recent activity
No call appearances or filed executive changes recorded yet.